Compare CTRA & MEDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CTRA | MEDP |
|---|---|---|
| Founded | 1989 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 19.6B | 16.1B |
| IPO Year | 1990 | 2016 |
| Metric | CTRA | MEDP |
|---|---|---|
| Price | $27.46 | $601.10 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 16 | 12 |
| Target Price | $32.69 | ★ $479.64 |
| AVG Volume (30 Days) | ★ 10.1M | 211.4K |
| Earning Date | 02-23-2026 | 02-09-2026 |
| Dividend Yield | ★ 3.21% | N/A |
| EPS Growth | ★ 31.20 | 25.36 |
| EPS | 2.17 | ★ 14.32 |
| Revenue | ★ $6,666,000,000.00 | $2,358,373,000.00 |
| Revenue This Year | $46.41 | $21.43 |
| Revenue Next Year | $2.66 | $11.99 |
| P/E Ratio | ★ $12.64 | $42.04 |
| Revenue Growth | ★ 25.92 | 13.88 |
| 52 Week Low | $22.33 | $250.05 |
| 52 Week High | $29.82 | $628.92 |
| Indicator | CTRA | MEDP |
|---|---|---|
| Relative Strength Index (RSI) | 66.59 | 53.32 |
| Support Level | $25.89 | $579.03 |
| Resistance Level | $27.90 | $624.00 |
| Average True Range (ATR) | 0.90 | 18.86 |
| MACD | 0.24 | -1.26 |
| Stochastic Oscillator | 74.47 | 44.61 |
Coterra Energy Inc is an independent oil and gas company engaged in the development, exploration, and production of oil, natural gas, and natural gas liquids (NGLs). Its operations are mainly concentrated in areas with hydrocarbon resources, which are conducive to multi-well, repeatable development programs, and include the Permian Basin located in Texas and New Mexico, the Marcellus Shale in northeast Pennsylvania, and the Anadarko Basin located in the mid-continent region in Oklahoma. The company operates in one segment, oil and natural gas development, exploration, and production, in the continental U.S.
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.